USFDA concludes inspection at Alkem Laboratories’ API manufacturing facility in Maharashtra

02 Dec 2023 Evaluate

U.S Food and Drug Administration (USFDA) has concluded inspection at Alkem Laboratories’ API manufacturing facility located at Mandva, Maharashtra. The said inspection conducted from November 27, 2023 to December 01, 2023. At the end of the inspection, the Company has received Form 483 with three observations. There is no data integrity observation. 

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5581.05 -21.95 (-0.39%)
22-Nov-2024 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1215.35
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 947.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.